NEW Delhi: Bliss GVS Pharma on has reported a 22 per cent increase in consolidated profit to Rs 41.45 crore in the second quarter ended September 30, 2018. Bliss GVS Pharma had posted a profit of Rs 33.98 crore in the same period a year ago.
Bliss GVS Pharma is an Indian pharmaceutical and company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others
Total income of the company increased by 4.8 per cent to Rs 253.3 crore from Rs 241.7 crore during the period under review.